NDC Compounded Drug 71449-134-32 Epinephrine; Bupivacaine Hydrochloride; Dexamethasone Sodium Phosphate
Injection, Solution Infiltration
Compounded Drug Product Information
NDC Crossover Products Matching Epinephrine; Bupivacaine Hydrochloride; Dexamethasone Sodium Phosphate
NDC crossover of Bupivacaine, Dexamethasone, Epinephrine Preservative Free with NDC 71449-134 a human compounded drug with other similar products matching the same substance name (Epinephrine; Bupivacaine Hydrochloride; Dexamethasone Sodium Phosphate) and the same administration route (infiltration) or dosage form (injection, solution).
NDC | Proprietary Name | Non-Proprietary Name | Package Desc | Dosage Form | Route Name | Company Name |
---|---|---|---|---|---|---|
71449-127-32 | Bupivacaine, Dexamethasone, Epinephrine | Bupivacaine, Dexamethasone, Epinephrine | 5 SYRINGE, PLASTIC in 1 CONTAINER > 30 mL in 1 SYRINGE, PLASTIC | Injection, Solution | Infiltration | Denver Solutions, Llc Dba Leiters Health |
Frequently Asked Questions
What is the NDC number assigned to Bupivacaine, Dexamethasone, Epinephrine?
Bupivacaine, Dexamethasone, Epinephrine was assigned by its manufacturer with NDC product code 71449-134. This product is a drug classified as a human compounded drug. Compounded drugs are medications created by combining or altering existing drugs to meet the specific needs of certain patients. The NDC directory only includes information about compounded drugs from facilities that choose to assign NDC numbers to their products.
Which are the NDC package codes for Bupivacaine, Dexamethasone, Epinephrine?
The NDC package code 71449-134-32 was assigned to a 5 SYRINGE, PLASTIC in 1 CONTAINER > 30 mL in 1 SYRINGE, PLASTIC of epinephrine; bupivacaine hydrochloride; dexamethasone sodium phosphate administered infiltration via injection, solution.
Who manufactures this product?
Bupivacaine, Dexamethasone, Epinephrine is manufactured by an outsourced facility and labeled by Denver Solutions, Llc Dba Leiters Health. All compounded drugs included in the NDC directory are classified as "Outsourcing Facility Compounded Human Drug Product (Exempt from Approval Requirements)". Outsourcing facilities are a type of drug compounding facility regulated under Section 503B of the FD&C Act could be eligible for exemptions from drug registration if they meet all the conditions specified under Section 503B.
Which are the NDC crossover matchings for this product?
We found 1 matching products that have the same substance, dosage form and administration route. The matching products are manufactured by Denver Solutions, LLC dba Leiters Health with NDC product codes 71449-127-32.